Drug utilization pattern of romosozumab and other osteoporosis treatments in Japan, 2019-2021.

Satoshi Soen Alex Y Wang Etsuro Hamaya Hsu-Chih Chien Tzu-Chieh Lin

Published in: Journal of bone and mineral metabolism (2024)

Patients initiating romosozumab and TPTD had a high fracture history. Given the dual effects of promoting bone formation and suppressing resorption, improving romosozumab adherence and persistence over time may be important for antiosteoporotic therapy.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
postmenopausal women
signaling pathway
emergency department
type diabetes
bone mineral density
metabolic syndrome
adipose tissue
electronic health record